Study of a new injection for Parkinson's motor fluctuations
Part of Brain & nervous system clinical trials.
This trial tests an injection that may help reduce Parkinson's symptoms when they fluctuate, such as when medication wears off. It is for people who are already taking levodopa but still have periods of poor symptom control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 30 years of age or older.
- You have been diagnosed with Parkinson's disease by a doctor.
- You are currently taking levodopa (a common Parkinson's medication) and have been on a stable dose for at least 4 weeks.
- You experience motor fluctuations, meaning your symptoms vary between good and bad periods during the day.
- Your Parkinson's symptoms are moderate to severe when your medication is not working well (Hoehn-Yahr stage 2 or higher).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication called Lu AF28996 to help reduce the periods when Parkinson's symptoms worsen throughout the day (called 'OFF times'). If you have motor fluctuations that are predictable and affecting your daily life, this study might help you experience fewer of these difficult periods.
This trial tests an experimental injection (UX-DA003) that may help people with advanced Parkinson’s disease whose current medications are losing effect. The goal is to see if it improves movement and reduces daily 'off' time.
This study looks at a new pump treatment (foslevodopa/foscarbidopa) for people with advanced Parkinson's who are having motor fluctuations. It aims to see if it improves quality of life when started earlier in the advanced stage.
This study tests a new form of Parkinson's medication given through a pump to see how well it works in everyday life for people in the early stages of advanced Parkinson's. It may help control symptoms and improve daily function.
This trial tests an experimental drug called RO7568282 to see if it is safe and can help with early Parkinson's disease symptoms. It is for people who have been taking a stable dose of levodopa alone for at least two months.
This trial tests a new experimental drug called ALN-SNCA, given as an injection into the spinal fluid, for people with early Parkinson's disease. The goal is to see if it is safe and well-tolerated.
Hear when a new Parkinson’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.